Skip to content

Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial

Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05159765
Acronym
PROTECT
Enrollment
144
Registered
2021-12-16
Start date
2022-01-22
Completion date
2026-02-28
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Keywords

Myopia, Refractive Error

Brief summary

This is a multi-center, randomized, double-masked clinical trial. All study devices are market approved/cleared in the localities where the study is conducted. Subjects will be randomly assigned to wear NaturalVue Sphere single vision contact lenses (SVCL) or NaturalVue Multifocal (NVMF) soft contact lenses for a total of three years.

Interventions

Wearing contact lenses during waking hours may alter the progression of myopia

Wearing contact lenses during waking hours may alter the progression of myopia

Sponsors

Visioneering Technologies, Inc
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
7 Years to 13 Years
Healthy volunteers
Yes

Inclusion criteria

1. Male or female, aged 7 to \<13 (inclusive) at the Screening/Baseline examination. 2. Meet the following refractive criteria determined by cycloplegic autorefraction at Screening/Baseline: * Spherical Equivalent Refractive Error (SERE): between -0.75 and -5.00 D inclusive. * Astigmatism: ≤ -0.75 D * Anisometropia: \< 1.000

Exclusion criteria

1. Has previously worn or currently wears rigid or gas permeable contact lenses, including orthokeratology lenses, 2. Appears to exhibit poor personal hygiene, that, in the Investigator's opinion, might prevent safe contact lens wear. 3. Is currently, or within 30 days prior to this study has been, an active participant in another clinical study. 4. Current or prior use of bifocals, progressive addition lenses, atropine, pirenzepine, multifocal or specialized contact lenses, or ANY other myopia control treatment. 5. The Investigator for any reason considers that it is not in the best interest of the subject to participate in the study, including if the child is not mature enough to independently handle and care for soft contact lenses.

Design outcomes

Primary

MeasureTime frameDescription
Change in Refractive Error relative to BaselineBaseline, 12, 24, 36 monthsMean change in cycloplegic auto-refraction (D)

Secondary

MeasureTime frameDescription
Change in Axial LengthBaseline,12, 24, 36 monthsMean change in Axial Length (mm)

Countries

Canada, Hong Kong, Singapore, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026